Understanding how lung cells respond to injury during respiratory infections
AP-1 as a transcriptional regulator of AT2 cell reversible activation during lung injury response
This study looks at how special lung cells help heal damage from respiratory infections like COVID-19, using mice to understand how these cells work during recovery and what changes happen in their genes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10911375 on NIH RePORTER |
What this research studies
This research investigates the role of alveolar type II (AT2) cells in the lung's response to injury, particularly during respiratory infections like COVID-19. By using a mouse model, the study examines how these stem cells activate to repair lung damage and how they behave during the recovery phase. The researchers utilize advanced techniques such as ATAC-sequencing to analyze the genetic changes in AT2 cells during these processes, aiming to uncover the mechanisms that govern their activation and reversion to a resting state.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced acute lung injury or severe respiratory infections, particularly those related to COVID-19.
Not a fit: Patients with chronic lung conditions that do not involve acute injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that enhance lung repair mechanisms in patients suffering from severe respiratory infections.
How similar studies have performed: Previous research has shown promising results in understanding lung cell behavior during injury, suggesting that this approach could yield valuable insights.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Lynch, Anne — Baylor College of Medicine
- Study coordinator: Lynch, Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.